Jagsonpal Pharma: Trading Window Closed for Q2 FY27 Results
Jagsonpal Pharmaceuticals Limited has announced the closure of its trading window for designated persons and their immediate relatives. This closure is effective from October 1, 2026, and will remain in effect until 48 hours after the declaration of the unaudited financial results for the quarter and six months ended September 30, 2026. The company will announce the date of the board meeting to approve these results in due course. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
Key Highlights
- Trading window closed from October 1, 2026.
- Closure is for designated persons and immediate relatives.
- Window reopens 48 hours after Q2 FY27 results declaration.
- Results for quarter and six months ended September 30, 2026.
Price Impact
More from JAGSNPHARM
Jagsonpal Pharmaceuticals Board Meeting on Oct 28 to Approve Q2 Results
Jagsonpal Pharmaceuticals Consummates Group Pharma Wellness Portfolio Acquisition
Jagsonpal Pharma Acquires Group Pharma Wellness Portfolio for ₹46.7 Cr